Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Latest test results for lafora in dachshunds
Image mini wire haired dachshund
Latest tests show 8 per cent of dachshunds were affected.
Screenings show 42 per cent are carriers

Recent screenings for lafora's disease in miniature wire-haired dachshunds has revealed that 42 per cent of those tested are carriers of the disease.

The Dachshund Breed Council has reported the findings, which are in line with earlier results. Screenings from last November show 8 per cent of participating dogs were affected with lafora, while 50 per cent were clear.

Lafora's disease is a late-onset form of epilepsy affecting miniature wire-haired dachshunds, as well as beagles and basset hounds. Symptoms include the development of head and neck jerking when the dog is stimulated. Over time, it can lead to blindness and dementia.

The test is offered by Dr Berge Minassian from the Hospital for Sick Children in Canada, and was developed in conjunction with the Wire-Haired Dachshund club.

More than 400 dogs have now been tested and received their results. Of these, 250 were tested with the full DNA affected/carrier/clear test.

The breed council has urged breeders and stud dog owners to offer their support to the testing programme, by only breeding dogs that have received a negative test result for lafora.

Owners of the 8 per cent of dogs found to be affected with lafora have been encouraged to join the active Lafora Support Group and participate in the lafora progression research project, which aims to improve understanding of the management of the disease.

Speaking at the breed council's recent Neurology seminar in Surrey, neurology expert Dr Clare Rusbridge, said 45 per cent of an affected dog's life could be spent suffering debilitating jerking, seizures, confusion, anxiety, possible hallucination, difficulty walking and blindness.

Test results have been supplied to the Kennel Club and a new DNA testing scheme for the disease has been approved.

 

Become a member or log in to add this story to your CPD history

Annual submission deadline small pet animal exemptions

News Story 1
 Companies marketing medicines for small pets exempt from authorisation must submit their annual return to the Veterinary Medicines Directorate (VMD) by 30 November 2026.

Submitting this annual return ensures continued compliance with regulatory requirements for products marketed without a full Marketing Authorisation. The exemption specifically applies to products intended for animals, cage birds, terrarium animals, small rodents, ferrets and rabbits.

For further details and submission guidelines, visit the gov.uk website.  

Click here for more...
News Shorts
BVA urges 'continued vigilance' over bluetongue

The British Veterinary Association (BVA) has urged vigilance following a concerning rise in Bluetongue (BTV) cases in sheep and cattle.

In a recent statement, the BVA noted that members are reporting more severe clinical signs and higher mortality rates than in previous years.

'We know that farm vets are working hard to support farmers and animals affected by this outbreak, during what is an extremely difficult time for all involved,' they stated. 'Continued vigilance to identify disease early is vital and vaccination remains the best way of protecting animals from this disease.'